Alzheimer's disease and Alzheimer's disease-related dementias
3 papers2 findings
- Humans3
Associations
2Semaglutide
upin humans1HR 1.32
1 study
Semaglutide
upin humans1HR 1.32
Semaglutide raises the risk of Alzheimer's disease and Alzheimer's disease-related dementias in humans (HR 1.32, 95% CI 1.08, 1.62).
“Semaglutide had a higher risk of AD/ADRD than dulaglutide (HR 1.32, 95% CI 1.08, 1.62).”
Humanscompared to dulaglutide in veterans with T2D on metforminn = 21,173
AAIC 2025 abstract25 Dec 2025
Liraglutide
downin humans1HR 0.68
1 study
Liraglutide
downin humans1HR 0.68
Liraglutide lowers the risk of Alzheimer's disease and Alzheimer's disease-related dementias in humans (HR 0.68, 95% CI 0.55, 0.83).
“In IPW Cox regression models, liraglutide had a lower risk of AD/ADRD compared to semaglutide (HR 0.68, 95% CI 0.55, 0.83)”
Humanscompared to semaglutide in veterans with T2D on metforminn = 21,173
AAIC 2025 abstract25 Dec 2025
Latest
5 in 12 monthsJournal of Alzheimer's Disease
The impact of psychosocial factors on neurocognitive functioning in family caregivers of persons with Alzheimer's disease and related dementias
Cohort study of 42 peoplePopulations
GSA 2025 Abstract
Longitudinal Measurement Invariance of the Harmonized Cognitive Assessment Protocol in Mex-Cog
Study in peopleBiomarkers
AAIC 2025 Abstract
The Role of Diet in Dementia Prevention: Subjective and Objective Diet Scores
Cohort study of 117 peopleDementia
AAIC 2025 Abstract
Relationships of structural and load‐dependent arterial stiffness with cognition and AD/ADRD biomarkers: The Healthy Brain Study
Cohort study of 516 peopleBiomarkers